Fundraising Fox

Correlia Biosystems

YC W18 ↗

San Francisco, US · Delaware corporation · 16 employees · Inactive · 6 known investors

correliabio.com ↗

Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL. Aimed at pharmaceutical and proteomics researchers, it offers a faster alternative to traditional ELISA for protein measurement in laboratory workflows.

BiotechDeep TechHardwareHealthtechMedical DevicesLab-on-a-chipMicrofluidicsin /8775625@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W18)

AAAkwasi Apori
Akwasi AporiinFounder
KAKursad Araz
Kursad ArazinFounder/CTO
STSamuel Tia
Samuel TiainFounder

Investors · 6

Beresford VenturesOrlando
Blue Bear VenturesSan Francisco · $100K – $400K
Cota CapitalSan Francisco
Pallasite VenturesVancouver · $100K – $1.5M
Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M
Y CombinatorSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements
▶$1.3MraisedMay 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kittu KolluriDirector
  • Kursad ArazDirector
  • Akwasi AporiExecutive Officer, Director
Offering amount
$3.3M
Amount sold
$1.3M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.6MraisedOct 2020 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Akwasi AporiExecutive Officer, Director
  • Samuel TiaDirector
Offering amount
$9.6M
Amount sold
$9.6M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news